Comparison between l‐CHOP and an l‐CHOP protocol with interposed treatments of CCNU and MOPP (l‐CHOP‐CCNU‐MOPP) for lymphoma in dogs

An l-CHOP protocol with interposed treatments of CCNU and MOPP (l-CHOP-CCNU-MOPP) was evaluated in 66 dogs with stages III–V lymphoma. Results were compared with a historical group of 71 dogs treated with an l-CHOP protocol. Complete remission (CR) rates (85 and 80%, respectively) did not differ significantly between protocols (P = 0.48). First CR duration for dogs treated with l-CHOP-CCNU-MOPP was significantly longer: median, 317 days; 2-year CR rate, 35% versus median, 298 days; 2-year CR rate, 13%, P = 0.05). For the l-CHOP-CCNU-MOPP protocol, dogs in substage-b had a 4.3 times greater hazard of having a relapse than dogs in substage-a (P = 0.002). Frequency of adverse chemotherapy-associated gastrointestinal effects did not differ between protocols (P = 0.77). Neutropenia (primarily after CCNU) occurred more frequently in dogs treated with l-CHOP-CCNU-MOPP (P < 0.001). In summary, the l-CHOP-CCNU-MOPP protocol showed an improved duration of first CR as compared with an l-CHOP protocol, but the relevance of this finding might be subject to clinical judgement.